Novartis Pharmaceuticals rose over 200% in the US stock market before trading
六月清晨搅
发表于 2024-5-10 20:01:44
210
0
0
Novartis Pharmaceuticals rose over 200% in the US stock market, and the company has reached a multi billion dollar partnership with Sanofi.
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
转播
You may like
- Chinese concept stocks and US stocks generally rose before the market opened, with Bilibili rising nearly 4%
- Chinese concept stocks and US stocks generally strengthened before the market opened, and Futu Holdings rose more than 5%
- Bank of America survey: US stock market expected to be the best asset of 2025 after Trump's victory!
- Pfizer plans to sell hospital drug division, company responds
- Chinese concept stocks and US stocks mostly rose before the market, with extreme discounts and a nearly 6% increase
- Most US bank stocks rise, with JPMorgan Chase exceeding 1%
- Fuguo Bank's US stock market rose nearly 3% before trading
- RBC Capital raises target prices for multiple US bank stocks
- Micron Technology's US stock fell more than 14% in pre-market trading
- Jianxun Daily | Hengrui Pharmaceutical and IDEAYA signed an authorization agreement; Liu Zhongliang, the actual controller of Weikang Pharmaceutical, has been registered
